Pro DEX EV/EBIT PDEX

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2016.

Today, Oct 23, 2026: 16.0×
10-year median: 13.0×
Against its 10-year history: 74th; percentile: 0 is its lowest day, 100 its highest
10-year range: 6.0× to 23.0×
Peer median: 12.5×

Pro DEX's EV/EBIT is 16.0× as of Oct 23, 2026.

That is above its ten-year median of 13.0×, higher than on 74% of days in the last ten years.

Over that time it ranged from 6.0× in Feb 2018 to 23.0× in Sep 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 12.5×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	16.0×	11.6×	21.0×
2025	12.3×	8.8×	21.9×
2024	20.1×	11.6×	21.8×
2023	13.3×	11.7×	17.3×
2022	14.2×	10.7×	22.7×
2021	21.1×	14.8×	23.0×
2020	16.2×	9.3×	22.5×
2019	12.8×	6.8×	13.0×
2018	10.2×	6.0×	13.0×
2017	6.5×	6.5×	13.6×
2016	11.2×	10.4×	311×

Against its peers

Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.

Company	EV/EBIT
PDEXPro DEX	16.0×
UTMDUtah Medical Products	6.0×
INFUInfuSystem	22.4×
EMBCEmbecta	6.7×
KEQUKewaunee Scientific	7.2×
TCMDTactile Systems Technology	13.3×
MDXGMimedx	51.6×
APTAlpha Pro Tech	8.2×
MOVMovado	11.8×
NEPHNephros	20.5×
IRMDIradimed	37.7×
Peer median	12.5×

Where Pro DEX ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Pro DEX

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.